<DOC>
	<DOCNO>NCT01899235</DOCNO>
	<brief_summary>A randomised open-label pilot study assess safety efficacy treatment drug elute balloon alone coronary de novo lesion ) . Elective patient require PCI coronary de novo lesion vessel 2.5 mm - 4.0 mm .</brief_summary>
	<brief_title>The Treatment Coronary De-novo Lesions With Elutax Paclitaxel-eluting Balloon Alone , Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Patient ≥ 18years old Stable angina symptom Elective treatment coronary lesion Reference vessel diameter ≥ 2.5mm ≤ 4.0 mm visual inspection Left main stem lesion Bifurcation lesion Acute coronary syndrome ( UAP , NSTEMI , STEMI ) Cardiogenic shock Chronic total occlusion Additional lesion require PCI Platelet count ≤ 50 x 109/mm3 Left ventricular ejection fraction ≤ 30 % Patient life expectancy le 12 month Known allergy aspirin , clopidogrel , prasugrel , heparin , stainless steel , intravenous contrast ( severe ) , paclitaxel Participation another investigational drug device study Patient unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>